You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ANCOBON Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ancobon patents expire, and what generic alternatives are available?

Ancobon is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in ANCOBON is flucytosine. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the flucytosine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ancobon

A generic version of ANCOBON was approved as flucytosine by SIGMAPHARM LABS LLC on June 28th, 2011.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ANCOBON?
  • What are the global sales for ANCOBON?
  • What is Average Wholesale Price for ANCOBON?
Summary for ANCOBON
Drug patent expirations by year for ANCOBON
Drug Prices for ANCOBON

See drug prices for ANCOBON

Recent Clinical Trials for ANCOBON

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Yale UniversityPhase 2
National Institute of Neurological Disorders and Stroke (NINDS)Phase 2
Valeant Pharmaceuticals International, Inc.Phase 2

See all ANCOBON clinical trials

Pharmacology for ANCOBON

US Patents and Regulatory Information for ANCOBON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch ANCOBON flucytosine CAPSULE;ORAL 017001-001 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch ANCOBON flucytosine CAPSULE;ORAL 017001-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.